Ampraz Aimulle left atrial appendage embolization device
Taiwan·Risk Class 3·Abbot Medical;; St. Jude Medical Costa Rica Ltda.·Registered Aug 31, 2018 – Aug 31, 2028Active- Analysis ID
- a79ca81696e60c4771a461225f223d46
- Customs Code
- DHA05603151407
- Manufacturer Country
- Costa Rica;;United States
- Authorized Representative
- Abbott Medical Taiwan Co.
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.9999 Miscellaneous
- Import Information
- Contract manufacturing;; input
- Registration Date
- Aug 31, 2018
- Expiry Date
- Aug 31, 2028
Top companies providing products similar to "Ampraz Aimulle left atrial appendage embolization device"
Recently registered similar products
Access comprehensive regulatory information for Ampraz Aimulle left atrial appendage embolization device in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number a79ca81696e60c4771a461225f223d46 and manufactured by Abbot Medical;; St. Jude Medical Costa Rica Ltda.. The authorized representative in Taiwan is Abbott Medical Taiwan Co..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including St. Jude Medical Costa Rica Ltda.;; Abbott Medical, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.